New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
16:41 EDTVVUSVIVUS reports Q4 EPS (56c), consensus (44c)
Reports Q4 revenue $1.97M, consensus $3.09M. The increase in net loss was primarily attributable to higher selling, general and administrative expenses related to commercialization activities for Qsymia. In Q4, the company recognized net product revenues of $2M from sales of Qsymia.
News For VVUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 21, 2015
16:32 EDTVVUSVIVUS granted patents covering Qsymia compositions and methods
Subscribe for More Information
April 20, 2015
10:03 EDTVVUSHigh option volume stocks
Subscribe for More Information
April 15, 2015
19:34 EDTVVUSVIVUS files patent infringement lawsuit against Teva
Subscribe for More Information
April 14, 2015
07:10 EDTVVUSVIVUS says CVOT 'unlikely to initiate' in 2015
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use